Information provided from seizures and collected samples show that 4-BMC is mostly available on the drug market as a powder. Other physical forms, such as tablets and capsules have also been reported, but to a much smaller extent.
Recital 10, Directive (EU) 2025/2062
In forcesince 14 Oct 2025